SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001214659-18-005787
Filing Date
2018-08-29
Accepted
2018-08-29 16:58:32
Documents
2
Period of Report
2018-06-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-42814.html 4/A  
1 PRIMARY DOCUMENT marketforms-42814.xml 4/A 4157
2 POA DOCUMENT poa.htm EX-24 3972
  Complete submission text file 0001214659-18-005787.txt   9562
Mailing Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008
Business Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008 858-480-2400
OBALON THERAPEUTICS INC (Issuer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O OBALON THERAPEUTICS, INC. 5421 AVENIDA ENCINAS, SUITE F CARLSBAD CA 92008
Business Address
MOATAZEDI DAVID (Reporting) CIK: 0001700836 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37897 | Film No.: 181044858